IP Library Granted Patent US 11,660,259
Granted Patent B2
US 11,660,259 · App. 17/326,109 · Granted May 30, 2023

Magnolia extract containing compositions

Inventors: Jim Faller (Williamsville, NY); David Gan (Southlake, TX); Michelle Hines (Hickory Creek, TX); Lisa Mangos (Katy, TX)
Assignee: MARY KAY INC.
A61K8/347A61K8/042A61K8/06A61K8/062A61K8/35A61K8/498A61K8/553A61K8/64A61K8/678A61K8/73A61K8/9783A61K36/18A61K36/752A61Q19/00A61Q19/004A61Q19/007A61Q19/008A61Q19/08A61K2800/10A61K2800/522A61K2800/591A61K2800/782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,660,259
App. No.
17/326,109
Granted
May 30, 2023
Kind
B2
Abstract

Disclosed is a powder composition consisting essentially of Magnolia officinalis bark extract comprising magnolol and honokiol, tocopherol or tocopherol acetate, lecithin, at least one gum, and optionally water, wherein the composition is in powdered form.

Claims (16)

1. A powder composition consisting essentially an effective amount of:

(i) Magnolia officinalis bark extract comprising magnolol and honokiol;

(ii) tocopherol or tocopherol acetate;

(iii) lecithin;

(iv) at least one gum; and

(v) optionally water,

wherein the composition is in powdered form.

2. The powder composition of claim 1 , comprising water.

3. The powder composition of claim 2 , wherein the composition consists of (i)-(v).

4. The powder composition of claim 1 , wherein the at least one gum comprises dextrin.

5. The powder composition of claim 1 , wherein the lecithin is hydrogenated lecithin.

6. The powder composition of claim 1 , wherein the composition consists of (i)-(iv).

7. A method of reducing the appearance of dark circles, puffiness, or sagginess in the periorbital area of a person's skin, the method comprising topically applying to the skin in need thereof the composition of claim 1 .

8. A method for treating fine lines or wrinkles, the method comprising topically applying to skin in need thereof the composition of claim 1 .

9. A method of treating skin inflammation, the method comprising topically applying to skin in need thereof the composition of claim 1 .

10. A method of increasing firmness or elasticity or reducing the appearance of sagginess in the periorbital area of a person's skin, the method comprising topically applying to the skin in need thereof the composition of claim 1 .

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 069414/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2022
From: BELAJ INNOVATIONS, LLC
To: MARY KAY INC.
Reel/Frame 062144/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2021
From: FALLER, JIM; GAN, DAVID; HINES, MICHELLE; MANGOS, LISA
To: MARY KAY INC.
Reel/Frame 056964/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2021
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 056965/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2021
From: ALLUSTRA TECHNOLOGIES LLC
To: BELAJ INNOVATIONS LLC
Reel/Frame 056307/0001 →
Continuity (8)
Continuation 16554037 · Aug 28, 2019
Continuation 15816175 · Nov 17, 2017
Continuation 14289262 · May 28, 2014
Continuation 13297755 · Nov 16, 2011
Continuation 12706557 · Feb 16, 2010
Continuation 12048953 · Mar 14, 2008
Provisional Application 60912793 · Apr 19, 2007
Related Publication 20210267857A1 · Sep 2, 2021